Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

Clinical trial NCT00528723 · COMPLETED

Trial details

NCT number: NCT00528723
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bronchial Asthma

Start date: 2007-11-01
Primary completion: 2009-01-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.